nodes	percent_of_prediction	percent_of_DWPC	metapath
Alitretinoin—CYP1A2—Efavirenz—acquired immunodeficiency syndrome	0.0546	0.1	CbGbCtD
Alitretinoin—CYP1A2—Nevirapine—acquired immunodeficiency syndrome	0.0513	0.094	CbGbCtD
Alitretinoin—CYP1A2—Lopinavir—acquired immunodeficiency syndrome	0.0513	0.094	CbGbCtD
Alitretinoin—CYP1A2—Delavirdine—acquired immunodeficiency syndrome	0.0464	0.085	CbGbCtD
Alitretinoin—ABCB1—Lopinavir—acquired immunodeficiency syndrome	0.0449	0.0822	CbGbCtD
Alitretinoin—ABCB1—Amprenavir—acquired immunodeficiency syndrome	0.0406	0.0743	CbGbCtD
Alitretinoin—CYP1A2—Nelfinavir—acquired immunodeficiency syndrome	0.0389	0.0712	CbGbCtD
Alitretinoin—CYP1A2—Ritonavir—acquired immunodeficiency syndrome	0.0352	0.0644	CbGbCtD
Alitretinoin—ABCB1—Indinavir—acquired immunodeficiency syndrome	0.035	0.0642	CbGbCtD
Alitretinoin—ABCB1—Nelfinavir—acquired immunodeficiency syndrome	0.034	0.0623	CbGbCtD
Alitretinoin—ABCB1—Saquinavir—acquired immunodeficiency syndrome	0.0308	0.0563	CbGbCtD
Alitretinoin—ABCB1—Ritonavir—acquired immunodeficiency syndrome	0.0308	0.0563	CbGbCtD
Alitretinoin—ABCB1—Zidovudine—acquired immunodeficiency syndrome	0.0295	0.054	CbGbCtD
Alitretinoin—ABCB1—Lamivudine—acquired immunodeficiency syndrome	0.0228	0.0418	CbGbCtD
Alitretinoin—CRABP1—retina—acquired immunodeficiency syndrome	0.00372	0.0396	CbGeAlD
Alitretinoin—CRABP1—skin of body—acquired immunodeficiency syndrome	0.00326	0.0348	CbGeAlD
Alitretinoin—CRABP2—skin of body—acquired immunodeficiency syndrome	0.00295	0.0314	CbGeAlD
Alitretinoin—RARG—retina—acquired immunodeficiency syndrome	0.00245	0.0261	CbGeAlD
Alitretinoin—CRABP1—spinal cord—acquired immunodeficiency syndrome	0.0024	0.0255	CbGeAlD
Alitretinoin—CRABP2—digestive system—acquired immunodeficiency syndrome	0.00236	0.0251	CbGeAlD
Alitretinoin—CRABP1—vagina—acquired immunodeficiency syndrome	0.0023	0.0246	CbGeAlD
Alitretinoin—CRABP2—blood—acquired immunodeficiency syndrome	0.00225	0.024	CbGeAlD
Alitretinoin—CRABP2—spinal cord—acquired immunodeficiency syndrome	0.00217	0.0231	CbGeAlD
Alitretinoin—RARG—skin of body—acquired immunodeficiency syndrome	0.00215	0.0229	CbGeAlD
Alitretinoin—CRABP2—vagina—acquired immunodeficiency syndrome	0.00208	0.0222	CbGeAlD
Alitretinoin—CRABP1—nervous system—acquired immunodeficiency syndrome	0.00202	0.0215	CbGeAlD
Alitretinoin—CRABP2—lung—acquired immunodeficiency syndrome	0.00197	0.021	CbGeAlD
Alitretinoin—CRABP1—central nervous system—acquired immunodeficiency syndrome	0.00194	0.0207	CbGeAlD
Alitretinoin—RXRG—spinal cord—acquired immunodeficiency syndrome	0.00189	0.0202	CbGeAlD
Alitretinoin—RARB—vagina—acquired immunodeficiency syndrome	0.00186	0.0199	CbGeAlD
Alitretinoin—CRABP2—nervous system—acquired immunodeficiency syndrome	0.00183	0.0194	CbGeAlD
Alitretinoin—RXRA—nervous system—acquired immunodeficiency syndrome	0.00182	0.0194	CbGeAlD
Alitretinoin—RARB—lung—acquired immunodeficiency syndrome	0.00176	0.0188	CbGeAlD
Alitretinoin—CRABP2—central nervous system—acquired immunodeficiency syndrome	0.00176	0.0187	CbGeAlD
Alitretinoin—RXRA—central nervous system—acquired immunodeficiency syndrome	0.00175	0.0186	CbGeAlD
Alitretinoin—RARG—digestive system—acquired immunodeficiency syndrome	0.00172	0.0183	CbGeAlD
Alitretinoin—RXRB—vagina—acquired immunodeficiency syndrome	0.00171	0.0183	CbGeAlD
Alitretinoin—RARG—blood—acquired immunodeficiency syndrome	0.00164	0.0175	CbGeAlD
Alitretinoin—RARA—lymphoid tissue—acquired immunodeficiency syndrome	0.00164	0.0175	CbGeAlD
Alitretinoin—RXRB—lung—acquired immunodeficiency syndrome	0.00162	0.0173	CbGeAlD
Alitretinoin—RXRG—nervous system—acquired immunodeficiency syndrome	0.0016	0.017	CbGeAlD
Alitretinoin—CYP1A2—blood plasma—acquired immunodeficiency syndrome	0.00156	0.0166	CbGeAlD
Alitretinoin—CRABP1—brain—acquired immunodeficiency syndrome	0.00154	0.0164	CbGeAlD
Alitretinoin—RARA—blood—acquired immunodeficiency syndrome	0.00154	0.0164	CbGeAlD
Alitretinoin—RXRG—central nervous system—acquired immunodeficiency syndrome	0.00154	0.0164	CbGeAlD
Alitretinoin—RARG—vagina—acquired immunodeficiency syndrome	0.00152	0.0162	CbGeAlD
Alitretinoin—RXRB—nervous system—acquired immunodeficiency syndrome	0.0015	0.016	CbGeAlD
Alitretinoin—RARA—bone marrow—acquired immunodeficiency syndrome	0.00149	0.0159	CbGeAlD
Alitretinoin—RXRB—central nervous system—acquired immunodeficiency syndrome	0.00144	0.0154	CbGeAlD
Alitretinoin—RARG—lung—acquired immunodeficiency syndrome	0.00144	0.0153	CbGeAlD
Alitretinoin—CRABP2—brain—acquired immunodeficiency syndrome	0.0014	0.0149	CbGeAlD
Alitretinoin—RXRA—brain—acquired immunodeficiency syndrome	0.00139	0.0148	CbGeAlD
Alitretinoin—RARA—lung—acquired immunodeficiency syndrome	0.00135	0.0144	CbGeAlD
Alitretinoin—RARG—nervous system—acquired immunodeficiency syndrome	0.00133	0.0142	CbGeAlD
Alitretinoin—RARG—central nervous system—acquired immunodeficiency syndrome	0.00128	0.0137	CbGeAlD
Alitretinoin—RARA—nervous system—acquired immunodeficiency syndrome	0.00125	0.0133	CbGeAlD
Alitretinoin—RARB—brain—acquired immunodeficiency syndrome	0.00125	0.0133	CbGeAlD
Alitretinoin—RXRG—brain—acquired immunodeficiency syndrome	0.00122	0.013	CbGeAlD
Alitretinoin—RARB—lymph node—acquired immunodeficiency syndrome	0.00121	0.0128	CbGeAlD
Alitretinoin—RARA—central nervous system—acquired immunodeficiency syndrome	0.00121	0.0128	CbGeAlD
Alitretinoin—RXRB—brain—acquired immunodeficiency syndrome	0.00115	0.0122	CbGeAlD
Alitretinoin—RARG—brain—acquired immunodeficiency syndrome	0.00102	0.0108	CbGeAlD
Alitretinoin—RARG—lymph node—acquired immunodeficiency syndrome	0.000983	0.0105	CbGeAlD
Alitretinoin—RARA—brain—acquired immunodeficiency syndrome	0.000957	0.0102	CbGeAlD
Alitretinoin—RARA—lymph node—acquired immunodeficiency syndrome	0.000925	0.00985	CbGeAlD
Alitretinoin—ABCB1—blood plasma—acquired immunodeficiency syndrome	0.0008	0.00852	CbGeAlD
Alitretinoin—Acitretin—ALB—acquired immunodeficiency syndrome	0.000645	1	CrCbGaD
Alitretinoin—CYP1A2—digestive system—acquired immunodeficiency syndrome	0.0006	0.00639	CbGeAlD
Alitretinoin—CYP1A2—blood—acquired immunodeficiency syndrome	0.000572	0.00609	CbGeAlD
Alitretinoin—CYP1A2—lung—acquired immunodeficiency syndrome	0.000501	0.00534	CbGeAlD
Alitretinoin—ABCB1—retina—acquired immunodeficiency syndrome	0.000438	0.00467	CbGeAlD
Alitretinoin—ABCB1—lymphoid tissue—acquired immunodeficiency syndrome	0.000311	0.00332	CbGeAlD
Alitretinoin—ABCB1—digestive system—acquired immunodeficiency syndrome	0.000308	0.00328	CbGeAlD
Alitretinoin—ABCB1—blood—acquired immunodeficiency syndrome	0.000293	0.00312	CbGeAlD
Alitretinoin—ABCB1—bone marrow—acquired immunodeficiency syndrome	0.000283	0.00302	CbGeAlD
Alitretinoin—ABCB1—spinal cord—acquired immunodeficiency syndrome	0.000282	0.00301	CbGeAlD
Alitretinoin—ABCB1—vagina—acquired immunodeficiency syndrome	0.000272	0.00289	CbGeAlD
Alitretinoin—ABCB1—lung—acquired immunodeficiency syndrome	0.000257	0.00274	CbGeAlD
Alitretinoin—ABCB1—nervous system—acquired immunodeficiency syndrome	0.000238	0.00253	CbGeAlD
Alitretinoin—ABCB1—central nervous system—acquired immunodeficiency syndrome	0.000229	0.00244	CbGeAlD
Alitretinoin—ABCB1—brain—acquired immunodeficiency syndrome	0.000182	0.00194	CbGeAlD
Alitretinoin—ABCB1—lymph node—acquired immunodeficiency syndrome	0.000176	0.00187	CbGeAlD
Alitretinoin—Anaemia—Lamivudine—acquired immunodeficiency syndrome	0.0001	0.000279	CcSEcCtD
Alitretinoin—Anxiety—Ritonavir—acquired immunodeficiency syndrome	0.0001	0.000279	CcSEcCtD
Alitretinoin—Loss of consciousness—Saquinavir—acquired immunodeficiency syndrome	9.99e-05	0.000278	CcSEcCtD
Alitretinoin—Unspecified disorder of skin and subcutaneous tissue—Ritonavir—acquired immunodeficiency syndrome	9.98e-05	0.000278	CcSEcCtD
Alitretinoin—Gastrointestinal disorder—Indinavir—acquired immunodeficiency syndrome	9.95e-05	0.000277	CcSEcCtD
Alitretinoin—Pruritus—Abacavir—acquired immunodeficiency syndrome	9.94e-05	0.000277	CcSEcCtD
Alitretinoin—Fatigue—Indinavir—acquired immunodeficiency syndrome	9.94e-05	0.000277	CcSEcCtD
Alitretinoin—Anorexia—Delavirdine—acquired immunodeficiency syndrome	9.93e-05	0.000276	CcSEcCtD
Alitretinoin—Discomfort—Ritonavir—acquired immunodeficiency syndrome	9.93e-05	0.000276	CcSEcCtD
Alitretinoin—Musculoskeletal discomfort—Efavirenz—acquired immunodeficiency syndrome	9.92e-05	0.000276	CcSEcCtD
Alitretinoin—Cough—Saquinavir—acquired immunodeficiency syndrome	9.92e-05	0.000276	CcSEcCtD
Alitretinoin—Constipation—Indinavir—acquired immunodeficiency syndrome	9.86e-05	0.000274	CcSEcCtD
Alitretinoin—Pain—Indinavir—acquired immunodeficiency syndrome	9.86e-05	0.000274	CcSEcCtD
Alitretinoin—Insomnia—Efavirenz—acquired immunodeficiency syndrome	9.85e-05	0.000274	CcSEcCtD
Alitretinoin—Urticaria—Zidovudine—acquired immunodeficiency syndrome	9.85e-05	0.000274	CcSEcCtD
Alitretinoin—Convulsion—Saquinavir—acquired immunodeficiency syndrome	9.85e-05	0.000274	CcSEcCtD
Alitretinoin—Dry mouth—Ritonavir—acquired immunodeficiency syndrome	9.83e-05	0.000274	CcSEcCtD
Alitretinoin—Hypertension—Saquinavir—acquired immunodeficiency syndrome	9.81e-05	0.000273	CcSEcCtD
Alitretinoin—Body temperature increased—Zidovudine—acquired immunodeficiency syndrome	9.8e-05	0.000273	CcSEcCtD
Alitretinoin—Abdominal pain—Zidovudine—acquired immunodeficiency syndrome	9.8e-05	0.000273	CcSEcCtD
Alitretinoin—Diarrhoea—Nelfinavir—acquired immunodeficiency syndrome	9.79e-05	0.000272	CcSEcCtD
Alitretinoin—Paraesthesia—Efavirenz—acquired immunodeficiency syndrome	9.78e-05	0.000272	CcSEcCtD
Alitretinoin—Malaise—Lamivudine—acquired immunodeficiency syndrome	9.78e-05	0.000272	CcSEcCtD
Alitretinoin—Diarrhoea—Stavudine—acquired immunodeficiency syndrome	9.76e-05	0.000271	CcSEcCtD
Alitretinoin—Nausea—Didanosine—acquired immunodeficiency syndrome	9.76e-05	0.000271	CcSEcCtD
Alitretinoin—Hypotension—Delavirdine—acquired immunodeficiency syndrome	9.74e-05	0.000271	CcSEcCtD
Alitretinoin—Syncope—Lamivudine—acquired immunodeficiency syndrome	9.72e-05	0.000271	CcSEcCtD
Alitretinoin—Confusional state—Ritonavir—acquired immunodeficiency syndrome	9.72e-05	0.00027	CcSEcCtD
Alitretinoin—Dyspnoea—Efavirenz—acquired immunodeficiency syndrome	9.71e-05	0.00027	CcSEcCtD
Alitretinoin—Somnolence—Efavirenz—acquired immunodeficiency syndrome	9.68e-05	0.000269	CcSEcCtD
Alitretinoin—Arthralgia—Saquinavir—acquired immunodeficiency syndrome	9.68e-05	0.000269	CcSEcCtD
Alitretinoin—Chest pain—Saquinavir—acquired immunodeficiency syndrome	9.68e-05	0.000269	CcSEcCtD
Alitretinoin—Myalgia—Saquinavir—acquired immunodeficiency syndrome	9.68e-05	0.000269	CcSEcCtD
Alitretinoin—Anxiety—Saquinavir—acquired immunodeficiency syndrome	9.64e-05	0.000268	CcSEcCtD
Alitretinoin—Oedema—Ritonavir—acquired immunodeficiency syndrome	9.64e-05	0.000268	CcSEcCtD
Alitretinoin—Diarrhoea—Abacavir—acquired immunodeficiency syndrome	9.61e-05	0.000267	CcSEcCtD
Alitretinoin—Unspecified disorder of skin and subcutaneous tissue—Saquinavir—acquired immunodeficiency syndrome	9.61e-05	0.000267	CcSEcCtD
Alitretinoin—Dyspepsia—Efavirenz—acquired immunodeficiency syndrome	9.59e-05	0.000267	CcSEcCtD
Alitretinoin—Discomfort—Saquinavir—acquired immunodeficiency syndrome	9.56e-05	0.000266	CcSEcCtD
Alitretinoin—Loss of consciousness—Lamivudine—acquired immunodeficiency syndrome	9.53e-05	0.000265	CcSEcCtD
Alitretinoin—Feeling abnormal—Indinavir—acquired immunodeficiency syndrome	9.5e-05	0.000264	CcSEcCtD
Alitretinoin—Musculoskeletal discomfort—Delavirdine—acquired immunodeficiency syndrome	9.5e-05	0.000264	CcSEcCtD
Alitretinoin—Shock—Ritonavir—acquired immunodeficiency syndrome	9.48e-05	0.000264	CcSEcCtD
Alitretinoin—Decreased appetite—Efavirenz—acquired immunodeficiency syndrome	9.47e-05	0.000263	CcSEcCtD
Alitretinoin—Dry mouth—Saquinavir—acquired immunodeficiency syndrome	9.46e-05	0.000263	CcSEcCtD
Alitretinoin—Cough—Lamivudine—acquired immunodeficiency syndrome	9.46e-05	0.000263	CcSEcCtD
Alitretinoin—Dizziness—Nelfinavir—acquired immunodeficiency syndrome	9.46e-05	0.000263	CcSEcCtD
Alitretinoin—Nervous system disorder—Ritonavir—acquired immunodeficiency syndrome	9.45e-05	0.000263	CcSEcCtD
Alitretinoin—Thrombocytopenia—Ritonavir—acquired immunodeficiency syndrome	9.44e-05	0.000263	CcSEcCtD
Alitretinoin—Dizziness—Stavudine—acquired immunodeficiency syndrome	9.43e-05	0.000262	CcSEcCtD
Alitretinoin—Gastrointestinal pain—Indinavir—acquired immunodeficiency syndrome	9.43e-05	0.000262	CcSEcCtD
Alitretinoin—Insomnia—Delavirdine—acquired immunodeficiency syndrome	9.43e-05	0.000262	CcSEcCtD
Alitretinoin—Tachycardia—Ritonavir—acquired immunodeficiency syndrome	9.41e-05	0.000262	CcSEcCtD
Alitretinoin—Gastrointestinal disorder—Efavirenz—acquired immunodeficiency syndrome	9.4e-05	0.000262	CcSEcCtD
Alitretinoin—Convulsion—Lamivudine—acquired immunodeficiency syndrome	9.39e-05	0.000261	CcSEcCtD
Alitretinoin—Vomiting—Nevirapine—acquired immunodeficiency syndrome	9.39e-05	0.000261	CcSEcCtD
Alitretinoin—Fatigue—Efavirenz—acquired immunodeficiency syndrome	9.39e-05	0.000261	CcSEcCtD
Alitretinoin—Skin disorder—Ritonavir—acquired immunodeficiency syndrome	9.36e-05	0.00026	CcSEcCtD
Alitretinoin—Paraesthesia—Delavirdine—acquired immunodeficiency syndrome	9.36e-05	0.00026	CcSEcCtD
Alitretinoin—Confusional state—Saquinavir—acquired immunodeficiency syndrome	9.35e-05	0.00026	CcSEcCtD
Alitretinoin—Hyperhidrosis—Ritonavir—acquired immunodeficiency syndrome	9.32e-05	0.000259	CcSEcCtD
Alitretinoin—Constipation—Efavirenz—acquired immunodeficiency syndrome	9.31e-05	0.000259	CcSEcCtD
Alitretinoin—Pain—Efavirenz—acquired immunodeficiency syndrome	9.31e-05	0.000259	CcSEcCtD
Alitretinoin—Rash—Nevirapine—acquired immunodeficiency syndrome	9.31e-05	0.000259	CcSEcCtD
Alitretinoin—Dermatitis—Nevirapine—acquired immunodeficiency syndrome	9.31e-05	0.000259	CcSEcCtD
Alitretinoin—Dyspnoea—Delavirdine—acquired immunodeficiency syndrome	9.29e-05	0.000258	CcSEcCtD
Alitretinoin—Dizziness—Abacavir—acquired immunodeficiency syndrome	9.29e-05	0.000258	CcSEcCtD
Alitretinoin—Oedema—Saquinavir—acquired immunodeficiency syndrome	9.28e-05	0.000258	CcSEcCtD
Alitretinoin—Somnolence—Delavirdine—acquired immunodeficiency syndrome	9.27e-05	0.000258	CcSEcCtD
Alitretinoin—Headache—Nevirapine—acquired immunodeficiency syndrome	9.25e-05	0.000257	CcSEcCtD
Alitretinoin—Chest pain—Lamivudine—acquired immunodeficiency syndrome	9.23e-05	0.000257	CcSEcCtD
Alitretinoin—Myalgia—Lamivudine—acquired immunodeficiency syndrome	9.23e-05	0.000257	CcSEcCtD
Alitretinoin—Arthralgia—Lamivudine—acquired immunodeficiency syndrome	9.23e-05	0.000257	CcSEcCtD
Alitretinoin—Infection—Saquinavir—acquired immunodeficiency syndrome	9.22e-05	0.000256	CcSEcCtD
Alitretinoin—Anxiety—Lamivudine—acquired immunodeficiency syndrome	9.2e-05	0.000256	CcSEcCtD
Alitretinoin—Anorexia—Ritonavir—acquired immunodeficiency syndrome	9.19e-05	0.000256	CcSEcCtD
Alitretinoin—Dyspepsia—Delavirdine—acquired immunodeficiency syndrome	9.17e-05	0.000255	CcSEcCtD
Alitretinoin—Unspecified disorder of skin and subcutaneous tissue—Lamivudine—acquired immunodeficiency syndrome	9.17e-05	0.000255	CcSEcCtD
Alitretinoin—Urticaria—Indinavir—acquired immunodeficiency syndrome	9.16e-05	0.000255	CcSEcCtD
Alitretinoin—Shock—Saquinavir—acquired immunodeficiency syndrome	9.13e-05	0.000254	CcSEcCtD
Alitretinoin—Discomfort—Lamivudine—acquired immunodeficiency syndrome	9.12e-05	0.000254	CcSEcCtD
Alitretinoin—Abdominal pain—Indinavir—acquired immunodeficiency syndrome	9.11e-05	0.000254	CcSEcCtD
Alitretinoin—Body temperature increased—Indinavir—acquired immunodeficiency syndrome	9.11e-05	0.000254	CcSEcCtD
Alitretinoin—Nervous system disorder—Saquinavir—acquired immunodeficiency syndrome	9.1e-05	0.000253	CcSEcCtD
Alitretinoin—Vomiting—Nelfinavir—acquired immunodeficiency syndrome	9.1e-05	0.000253	CcSEcCtD
Alitretinoin—Thrombocytopenia—Saquinavir—acquired immunodeficiency syndrome	9.08e-05	0.000253	CcSEcCtD
Alitretinoin—Vomiting—Stavudine—acquired immunodeficiency syndrome	9.07e-05	0.000252	CcSEcCtD
Alitretinoin—Decreased appetite—Delavirdine—acquired immunodeficiency syndrome	9.06e-05	0.000252	CcSEcCtD
Alitretinoin—Dry mouth—Lamivudine—acquired immunodeficiency syndrome	9.03e-05	0.000251	CcSEcCtD
Alitretinoin—Rash—Nelfinavir—acquired immunodeficiency syndrome	9.02e-05	0.000251	CcSEcCtD
Alitretinoin—Dermatitis—Nelfinavir—acquired immunodeficiency syndrome	9.01e-05	0.000251	CcSEcCtD
Alitretinoin—Skin disorder—Saquinavir—acquired immunodeficiency syndrome	9.01e-05	0.000251	CcSEcCtD
Alitretinoin—Hypotension—Ritonavir—acquired immunodeficiency syndrome	9.01e-05	0.000251	CcSEcCtD
Alitretinoin—Gastrointestinal disorder—Delavirdine—acquired immunodeficiency syndrome	9e-05	0.00025	CcSEcCtD
Alitretinoin—Rash—Stavudine—acquired immunodeficiency syndrome	8.99e-05	0.00025	CcSEcCtD
Alitretinoin—Fatigue—Delavirdine—acquired immunodeficiency syndrome	8.99e-05	0.00025	CcSEcCtD
Alitretinoin—Dermatitis—Stavudine—acquired immunodeficiency syndrome	8.98e-05	0.00025	CcSEcCtD
Alitretinoin—Feeling abnormal—Efavirenz—acquired immunodeficiency syndrome	8.98e-05	0.00025	CcSEcCtD
Alitretinoin—Hyperhidrosis—Saquinavir—acquired immunodeficiency syndrome	8.97e-05	0.000249	CcSEcCtD
Alitretinoin—Headache—Nelfinavir—acquired immunodeficiency syndrome	8.96e-05	0.000249	CcSEcCtD
Alitretinoin—Headache—Stavudine—acquired immunodeficiency syndrome	8.93e-05	0.000249	CcSEcCtD
Alitretinoin—Vomiting—Abacavir—acquired immunodeficiency syndrome	8.93e-05	0.000249	CcSEcCtD
Alitretinoin—Confusional state—Lamivudine—acquired immunodeficiency syndrome	8.92e-05	0.000248	CcSEcCtD
Alitretinoin—Pain—Delavirdine—acquired immunodeficiency syndrome	8.91e-05	0.000248	CcSEcCtD
Alitretinoin—Constipation—Delavirdine—acquired immunodeficiency syndrome	8.91e-05	0.000248	CcSEcCtD
Alitretinoin—Gastrointestinal pain—Efavirenz—acquired immunodeficiency syndrome	8.91e-05	0.000248	CcSEcCtD
Alitretinoin—Asthenia—Zidovudine—acquired immunodeficiency syndrome	8.89e-05	0.000247	CcSEcCtD
Alitretinoin—Rash—Abacavir—acquired immunodeficiency syndrome	8.86e-05	0.000246	CcSEcCtD
Alitretinoin—Dermatitis—Abacavir—acquired immunodeficiency syndrome	8.85e-05	0.000246	CcSEcCtD
Alitretinoin—Oedema—Lamivudine—acquired immunodeficiency syndrome	8.85e-05	0.000246	CcSEcCtD
Alitretinoin—Anaphylactic shock—Lamivudine—acquired immunodeficiency syndrome	8.85e-05	0.000246	CcSEcCtD
Alitretinoin—Anorexia—Saquinavir—acquired immunodeficiency syndrome	8.84e-05	0.000246	CcSEcCtD
Alitretinoin—Headache—Abacavir—acquired immunodeficiency syndrome	8.8e-05	0.000245	CcSEcCtD
Alitretinoin—Infection—Lamivudine—acquired immunodeficiency syndrome	8.79e-05	0.000245	CcSEcCtD
Alitretinoin—Musculoskeletal discomfort—Ritonavir—acquired immunodeficiency syndrome	8.78e-05	0.000244	CcSEcCtD
Alitretinoin—Nausea—Nevirapine—acquired immunodeficiency syndrome	8.77e-05	0.000244	CcSEcCtD
Alitretinoin—Pruritus—Zidovudine—acquired immunodeficiency syndrome	8.77e-05	0.000244	CcSEcCtD
Alitretinoin—Insomnia—Ritonavir—acquired immunodeficiency syndrome	8.72e-05	0.000243	CcSEcCtD
Alitretinoin—Shock—Lamivudine—acquired immunodeficiency syndrome	8.71e-05	0.000242	CcSEcCtD
Alitretinoin—Nervous system disorder—Lamivudine—acquired immunodeficiency syndrome	8.68e-05	0.000241	CcSEcCtD
Alitretinoin—Hypotension—Saquinavir—acquired immunodeficiency syndrome	8.67e-05	0.000241	CcSEcCtD
Alitretinoin—Thrombocytopenia—Lamivudine—acquired immunodeficiency syndrome	8.66e-05	0.000241	CcSEcCtD
Alitretinoin—Paraesthesia—Ritonavir—acquired immunodeficiency syndrome	8.65e-05	0.000241	CcSEcCtD
Alitretinoin—Urticaria—Efavirenz—acquired immunodeficiency syndrome	8.65e-05	0.000241	CcSEcCtD
Alitretinoin—Abdominal pain—Efavirenz—acquired immunodeficiency syndrome	8.61e-05	0.00024	CcSEcCtD
Alitretinoin—Body temperature increased—Efavirenz—acquired immunodeficiency syndrome	8.61e-05	0.00024	CcSEcCtD
Alitretinoin—Skin disorder—Lamivudine—acquired immunodeficiency syndrome	8.6e-05	0.000239	CcSEcCtD
Alitretinoin—Dyspnoea—Ritonavir—acquired immunodeficiency syndrome	8.59e-05	0.000239	CcSEcCtD
Alitretinoin—Feeling abnormal—Delavirdine—acquired immunodeficiency syndrome	8.59e-05	0.000239	CcSEcCtD
Alitretinoin—Somnolence—Ritonavir—acquired immunodeficiency syndrome	8.57e-05	0.000238	CcSEcCtD
Alitretinoin—Hyperhidrosis—Lamivudine—acquired immunodeficiency syndrome	8.55e-05	0.000238	CcSEcCtD
Alitretinoin—Gastrointestinal pain—Delavirdine—acquired immunodeficiency syndrome	8.52e-05	0.000237	CcSEcCtD
Alitretinoin—Nausea—Nelfinavir—acquired immunodeficiency syndrome	8.5e-05	0.000236	CcSEcCtD
Alitretinoin—Hypersensitivity—Indinavir—acquired immunodeficiency syndrome	8.49e-05	0.000236	CcSEcCtD
Alitretinoin—Dyspepsia—Ritonavir—acquired immunodeficiency syndrome	8.48e-05	0.000236	CcSEcCtD
Alitretinoin—Diarrhoea—Zidovudine—acquired immunodeficiency syndrome	8.48e-05	0.000236	CcSEcCtD
Alitretinoin—Nausea—Stavudine—acquired immunodeficiency syndrome	8.47e-05	0.000236	CcSEcCtD
Alitretinoin—Musculoskeletal discomfort—Saquinavir—acquired immunodeficiency syndrome	8.45e-05	0.000235	CcSEcCtD
Alitretinoin—Anorexia—Lamivudine—acquired immunodeficiency syndrome	8.44e-05	0.000235	CcSEcCtD
Alitretinoin—Insomnia—Saquinavir—acquired immunodeficiency syndrome	8.39e-05	0.000233	CcSEcCtD
Alitretinoin—Decreased appetite—Ritonavir—acquired immunodeficiency syndrome	8.38e-05	0.000233	CcSEcCtD
Alitretinoin—Nausea—Abacavir—acquired immunodeficiency syndrome	8.35e-05	0.000232	CcSEcCtD
Alitretinoin—Paraesthesia—Saquinavir—acquired immunodeficiency syndrome	8.33e-05	0.000232	CcSEcCtD
Alitretinoin—Gastrointestinal disorder—Ritonavir—acquired immunodeficiency syndrome	8.32e-05	0.000231	CcSEcCtD
Alitretinoin—Fatigue—Ritonavir—acquired immunodeficiency syndrome	8.31e-05	0.000231	CcSEcCtD
Alitretinoin—Urticaria—Delavirdine—acquired immunodeficiency syndrome	8.28e-05	0.00023	CcSEcCtD
Alitretinoin—Asthenia—Indinavir—acquired immunodeficiency syndrome	8.27e-05	0.00023	CcSEcCtD
Alitretinoin—Dyspnoea—Saquinavir—acquired immunodeficiency syndrome	8.27e-05	0.00023	CcSEcCtD
Alitretinoin—Hypotension—Lamivudine—acquired immunodeficiency syndrome	8.27e-05	0.00023	CcSEcCtD
Alitretinoin—Somnolence—Saquinavir—acquired immunodeficiency syndrome	8.25e-05	0.000229	CcSEcCtD
Alitretinoin—Constipation—Ritonavir—acquired immunodeficiency syndrome	8.24e-05	0.000229	CcSEcCtD
Alitretinoin—Pain—Ritonavir—acquired immunodeficiency syndrome	8.24e-05	0.000229	CcSEcCtD
Alitretinoin—Abdominal pain—Delavirdine—acquired immunodeficiency syndrome	8.24e-05	0.000229	CcSEcCtD
Alitretinoin—Body temperature increased—Delavirdine—acquired immunodeficiency syndrome	8.24e-05	0.000229	CcSEcCtD
Alitretinoin—Dizziness—Zidovudine—acquired immunodeficiency syndrome	8.2e-05	0.000228	CcSEcCtD
Alitretinoin—Dyspepsia—Saquinavir—acquired immunodeficiency syndrome	8.17e-05	0.000227	CcSEcCtD
Alitretinoin—Pruritus—Indinavir—acquired immunodeficiency syndrome	8.16e-05	0.000227	CcSEcCtD
Alitretinoin—Decreased appetite—Saquinavir—acquired immunodeficiency syndrome	8.06e-05	0.000224	CcSEcCtD
Alitretinoin—Musculoskeletal discomfort—Lamivudine—acquired immunodeficiency syndrome	8.06e-05	0.000224	CcSEcCtD
Alitretinoin—Hypersensitivity—Efavirenz—acquired immunodeficiency syndrome	8.03e-05	0.000223	CcSEcCtD
Alitretinoin—Gastrointestinal disorder—Saquinavir—acquired immunodeficiency syndrome	8.01e-05	0.000223	CcSEcCtD
Alitretinoin—Insomnia—Lamivudine—acquired immunodeficiency syndrome	8e-05	0.000223	CcSEcCtD
Alitretinoin—Fatigue—Saquinavir—acquired immunodeficiency syndrome	8e-05	0.000222	CcSEcCtD
Alitretinoin—Paraesthesia—Lamivudine—acquired immunodeficiency syndrome	7.95e-05	0.000221	CcSEcCtD
Alitretinoin—Feeling abnormal—Ritonavir—acquired immunodeficiency syndrome	7.94e-05	0.000221	CcSEcCtD
Alitretinoin—Constipation—Saquinavir—acquired immunodeficiency syndrome	7.93e-05	0.000221	CcSEcCtD
Alitretinoin—Pain—Saquinavir—acquired immunodeficiency syndrome	7.93e-05	0.000221	CcSEcCtD
Alitretinoin—Dyspnoea—Lamivudine—acquired immunodeficiency syndrome	7.89e-05	0.000219	CcSEcCtD
Alitretinoin—Diarrhoea—Indinavir—acquired immunodeficiency syndrome	7.89e-05	0.000219	CcSEcCtD
Alitretinoin—Vomiting—Zidovudine—acquired immunodeficiency syndrome	7.88e-05	0.000219	CcSEcCtD
Alitretinoin—Gastrointestinal pain—Ritonavir—acquired immunodeficiency syndrome	7.88e-05	0.000219	CcSEcCtD
Alitretinoin—Somnolence—Lamivudine—acquired immunodeficiency syndrome	7.87e-05	0.000219	CcSEcCtD
Alitretinoin—Rash—Zidovudine—acquired immunodeficiency syndrome	7.82e-05	0.000217	CcSEcCtD
Alitretinoin—Asthenia—Efavirenz—acquired immunodeficiency syndrome	7.82e-05	0.000217	CcSEcCtD
Alitretinoin—Dermatitis—Zidovudine—acquired immunodeficiency syndrome	7.81e-05	0.000217	CcSEcCtD
Alitretinoin—Dyspepsia—Lamivudine—acquired immunodeficiency syndrome	7.79e-05	0.000217	CcSEcCtD
Alitretinoin—Headache—Zidovudine—acquired immunodeficiency syndrome	7.77e-05	0.000216	CcSEcCtD
Alitretinoin—Pruritus—Efavirenz—acquired immunodeficiency syndrome	7.71e-05	0.000214	CcSEcCtD
Alitretinoin—Decreased appetite—Lamivudine—acquired immunodeficiency syndrome	7.69e-05	0.000214	CcSEcCtD
Alitretinoin—Hypersensitivity—Delavirdine—acquired immunodeficiency syndrome	7.68e-05	0.000214	CcSEcCtD
Alitretinoin—Urticaria—Ritonavir—acquired immunodeficiency syndrome	7.66e-05	0.000213	CcSEcCtD
Alitretinoin—Feeling abnormal—Saquinavir—acquired immunodeficiency syndrome	7.64e-05	0.000213	CcSEcCtD
Alitretinoin—Gastrointestinal disorder—Lamivudine—acquired immunodeficiency syndrome	7.64e-05	0.000213	CcSEcCtD
Alitretinoin—Fatigue—Lamivudine—acquired immunodeficiency syndrome	7.63e-05	0.000212	CcSEcCtD
Alitretinoin—Dizziness—Indinavir—acquired immunodeficiency syndrome	7.62e-05	0.000212	CcSEcCtD
Alitretinoin—Body temperature increased—Ritonavir—acquired immunodeficiency syndrome	7.62e-05	0.000212	CcSEcCtD
Alitretinoin—Abdominal pain—Ritonavir—acquired immunodeficiency syndrome	7.62e-05	0.000212	CcSEcCtD
Alitretinoin—Gastrointestinal pain—Saquinavir—acquired immunodeficiency syndrome	7.59e-05	0.000211	CcSEcCtD
Alitretinoin—Constipation—Lamivudine—acquired immunodeficiency syndrome	7.57e-05	0.000211	CcSEcCtD
Alitretinoin—Pain—Lamivudine—acquired immunodeficiency syndrome	7.57e-05	0.000211	CcSEcCtD
Alitretinoin—Asthenia—Delavirdine—acquired immunodeficiency syndrome	7.48e-05	0.000208	CcSEcCtD
Alitretinoin—Diarrhoea—Efavirenz—acquired immunodeficiency syndrome	7.45e-05	0.000207	CcSEcCtD
Alitretinoin—Pruritus—Delavirdine—acquired immunodeficiency syndrome	7.37e-05	0.000205	CcSEcCtD
Alitretinoin—Urticaria—Saquinavir—acquired immunodeficiency syndrome	7.37e-05	0.000205	CcSEcCtD
Alitretinoin—Nausea—Zidovudine—acquired immunodeficiency syndrome	7.36e-05	0.000205	CcSEcCtD
Alitretinoin—Abdominal pain—Saquinavir—acquired immunodeficiency syndrome	7.33e-05	0.000204	CcSEcCtD
Alitretinoin—Body temperature increased—Saquinavir—acquired immunodeficiency syndrome	7.33e-05	0.000204	CcSEcCtD
Alitretinoin—Vomiting—Indinavir—acquired immunodeficiency syndrome	7.33e-05	0.000204	CcSEcCtD
Alitretinoin—Feeling abnormal—Lamivudine—acquired immunodeficiency syndrome	7.29e-05	0.000203	CcSEcCtD
Alitretinoin—Rash—Indinavir—acquired immunodeficiency syndrome	7.27e-05	0.000202	CcSEcCtD
Alitretinoin—Dermatitis—Indinavir—acquired immunodeficiency syndrome	7.26e-05	0.000202	CcSEcCtD
Alitretinoin—Gastrointestinal pain—Lamivudine—acquired immunodeficiency syndrome	7.24e-05	0.000201	CcSEcCtD
Alitretinoin—Headache—Indinavir—acquired immunodeficiency syndrome	7.22e-05	0.000201	CcSEcCtD
Alitretinoin—Dizziness—Efavirenz—acquired immunodeficiency syndrome	7.2e-05	0.0002	CcSEcCtD
Alitretinoin—Diarrhoea—Delavirdine—acquired immunodeficiency syndrome	7.13e-05	0.000198	CcSEcCtD
Alitretinoin—Hypersensitivity—Ritonavir—acquired immunodeficiency syndrome	7.1e-05	0.000198	CcSEcCtD
Alitretinoin—Urticaria—Lamivudine—acquired immunodeficiency syndrome	7.03e-05	0.000196	CcSEcCtD
Alitretinoin—Abdominal pain—Lamivudine—acquired immunodeficiency syndrome	7e-05	0.000195	CcSEcCtD
Alitretinoin—Body temperature increased—Lamivudine—acquired immunodeficiency syndrome	7e-05	0.000195	CcSEcCtD
Alitretinoin—Vomiting—Efavirenz—acquired immunodeficiency syndrome	6.93e-05	0.000193	CcSEcCtD
Alitretinoin—Asthenia—Ritonavir—acquired immunodeficiency syndrome	6.91e-05	0.000192	CcSEcCtD
Alitretinoin—Dizziness—Delavirdine—acquired immunodeficiency syndrome	6.89e-05	0.000192	CcSEcCtD
Alitretinoin—Rash—Efavirenz—acquired immunodeficiency syndrome	6.87e-05	0.000191	CcSEcCtD
Alitretinoin—Dermatitis—Efavirenz—acquired immunodeficiency syndrome	6.86e-05	0.000191	CcSEcCtD
Alitretinoin—Nausea—Indinavir—acquired immunodeficiency syndrome	6.85e-05	0.000191	CcSEcCtD
Alitretinoin—Hypersensitivity—Saquinavir—acquired immunodeficiency syndrome	6.83e-05	0.00019	CcSEcCtD
Alitretinoin—Headache—Efavirenz—acquired immunodeficiency syndrome	6.82e-05	0.00019	CcSEcCtD
Alitretinoin—Pruritus—Ritonavir—acquired immunodeficiency syndrome	6.82e-05	0.00019	CcSEcCtD
Alitretinoin—Asthenia—Saquinavir—acquired immunodeficiency syndrome	6.66e-05	0.000185	CcSEcCtD
Alitretinoin—Vomiting—Delavirdine—acquired immunodeficiency syndrome	6.63e-05	0.000184	CcSEcCtD
Alitretinoin—Diarrhoea—Ritonavir—acquired immunodeficiency syndrome	6.59e-05	0.000183	CcSEcCtD
Alitretinoin—Rash—Delavirdine—acquired immunodeficiency syndrome	6.57e-05	0.000183	CcSEcCtD
Alitretinoin—Dermatitis—Delavirdine—acquired immunodeficiency syndrome	6.57e-05	0.000183	CcSEcCtD
Alitretinoin—Pruritus—Saquinavir—acquired immunodeficiency syndrome	6.56e-05	0.000183	CcSEcCtD
Alitretinoin—Headache—Delavirdine—acquired immunodeficiency syndrome	6.53e-05	0.000182	CcSEcCtD
Alitretinoin—Hypersensitivity—Lamivudine—acquired immunodeficiency syndrome	6.52e-05	0.000181	CcSEcCtD
Alitretinoin—Nausea—Efavirenz—acquired immunodeficiency syndrome	6.47e-05	0.00018	CcSEcCtD
Alitretinoin—Dizziness—Ritonavir—acquired immunodeficiency syndrome	6.37e-05	0.000177	CcSEcCtD
Alitretinoin—Asthenia—Lamivudine—acquired immunodeficiency syndrome	6.35e-05	0.000177	CcSEcCtD
Alitretinoin—Diarrhoea—Saquinavir—acquired immunodeficiency syndrome	6.35e-05	0.000177	CcSEcCtD
Alitretinoin—Pruritus—Lamivudine—acquired immunodeficiency syndrome	6.26e-05	0.000174	CcSEcCtD
Alitretinoin—Nausea—Delavirdine—acquired immunodeficiency syndrome	6.19e-05	0.000172	CcSEcCtD
Alitretinoin—Dizziness—Saquinavir—acquired immunodeficiency syndrome	6.13e-05	0.000171	CcSEcCtD
Alitretinoin—Vomiting—Ritonavir—acquired immunodeficiency syndrome	6.13e-05	0.00017	CcSEcCtD
Alitretinoin—Rash—Ritonavir—acquired immunodeficiency syndrome	6.08e-05	0.000169	CcSEcCtD
Alitretinoin—Dermatitis—Ritonavir—acquired immunodeficiency syndrome	6.07e-05	0.000169	CcSEcCtD
Alitretinoin—Diarrhoea—Lamivudine—acquired immunodeficiency syndrome	6.05e-05	0.000168	CcSEcCtD
Alitretinoin—Headache—Ritonavir—acquired immunodeficiency syndrome	6.04e-05	0.000168	CcSEcCtD
Alitretinoin—Vomiting—Saquinavir—acquired immunodeficiency syndrome	5.9e-05	0.000164	CcSEcCtD
Alitretinoin—Dizziness—Lamivudine—acquired immunodeficiency syndrome	5.85e-05	0.000163	CcSEcCtD
Alitretinoin—Rash—Saquinavir—acquired immunodeficiency syndrome	5.85e-05	0.000163	CcSEcCtD
Alitretinoin—Dermatitis—Saquinavir—acquired immunodeficiency syndrome	5.84e-05	0.000163	CcSEcCtD
Alitretinoin—Headache—Saquinavir—acquired immunodeficiency syndrome	5.81e-05	0.000162	CcSEcCtD
Alitretinoin—Nausea—Ritonavir—acquired immunodeficiency syndrome	5.72e-05	0.000159	CcSEcCtD
Alitretinoin—Vomiting—Lamivudine—acquired immunodeficiency syndrome	5.63e-05	0.000157	CcSEcCtD
Alitretinoin—Rash—Lamivudine—acquired immunodeficiency syndrome	5.58e-05	0.000155	CcSEcCtD
Alitretinoin—Dermatitis—Lamivudine—acquired immunodeficiency syndrome	5.57e-05	0.000155	CcSEcCtD
Alitretinoin—Headache—Lamivudine—acquired immunodeficiency syndrome	5.54e-05	0.000154	CcSEcCtD
Alitretinoin—Nausea—Saquinavir—acquired immunodeficiency syndrome	5.51e-05	0.000153	CcSEcCtD
Alitretinoin—Nausea—Lamivudine—acquired immunodeficiency syndrome	5.26e-05	0.000146	CcSEcCtD
